Trademark Overview
On Thursday, November 16, 2023, a trademark application was filed for EXABLATE PRIME with the United States Patent and Trademark Office. The USPTO has given the EXABLATE PRIME trademark a serial number of 98273591. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 24, 2024. This trademark is owned by Insightec Ltd.. The EXABLATE PRIME trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical Instrument Products categories with the following description:
Downloadable software for use in medical screening, diagnostics, and medical therapy, namely, for conducting guided ultrasound; downloadable computer software, namely, for the management and operation of medical ultrasound systems sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes; downloadable software for use in the treatment of neurological, oncological, gynecological, and urological disease by means of guided ultrasound; downloadable computer software for use in the treatment of central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases by means of guided ultrasound sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes
Medical ultrasound apparatus; ultrasound diagnostic apparatus and user manuals sold as a unit therewith; ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier, by itself or in combination with other therapies